antibody drug conjugates of trastuzumab for her2 mbc
Published 2 years ago • 23 plays • Length 5:30Download video MP4
Download video MP3
Similar videos
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
10:21
novel antibody-drug conjugates (adcs) technologies for management of mbc
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
5:40
【her2 inhibitors】trastuzumab(herceptin®), pertuzumab, lapatinib, antibody-drug conjugates (kadcyla®)
-
5:10
【her2乳癌】40歲工作狂人遇上her2型乳癌 康復後醒覺:沒甚麼重要過健康!|urbanlife health 健康新態度
-
8:25
new breast cancer drug delivers unprecedented levels of survival, stopping tumor growth
-
6:47
how to select treatment for her2 breast cancer patients with brain metastasis?
-
1:00:30
adc’s - what everyone with mbc should know about antibody drug conjugates
-
2:49
trastuzumab duocarmazine for her2 locally advanced or metastatic cancer
-
3:36
her2 breast cancer: evolution of antibody-drug conjugates
-
3:01
resistance to adcs in breast cancer and novel combination strategies
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
3:42
antibody drug conjugates in metastatic breast cancer | anthony elias, md | esmo22 colorado
-
2:10
targeting low her2 expression with antibody-drug conjugates
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
1:09
where are we in sequencing adcs in hr breast cancer?
-
2:12
trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
-
35:25
antibody drug conjugates and recent applications in breast cancer treatment
-
0:59
dr. linda vahdat on frontline eribulin plus trastuzumab in her2-positive mbc
-
2:59
trial demonstrates high efficacy of antibody drug conjugate in preventing early stage breast cancer
-
2:21
adcs for the treatment of her2-low breast cancer